|1.||Vapaatalo, Heikki: 3 articles (01/2014 - 01/2011)|
|2.||Yamamoto, Naoyuki: 2 articles (05/2013 - 05/2011)|
|3.||Turpeinen, Anu M: 2 articles (11/2011 - 01/2011)|
|4.||Korpela, Riitta: 2 articles (11/2011 - 01/2011)|
|5.||Ehlers, Pauliina I: 2 articles (11/2011 - 01/2011)|
|6.||Vapaatalo, H: 2 articles (12/2009 - 12/2001)|
|7.||Korpela, R: 2 articles (12/2009 - 12/2001)|
|8.||Wu, Jianping: 1 article (01/2015)|
|9.||Chakrabarti, Subhadeep: 1 article (01/2015)|
|10.||Osaka, Mizuko: 1 article (08/2014)|
|1.||Hypertension (High Blood Pressure)
05/01/2011 - "These results suggest that Val-Pro-Pro and Ile-Pro-Pro decrease blood pressure in patients with stage I hypertension and result not only in lower blood pressure at night-time but also in lower early-morning SBP in nondipper patients."
11/01/2011 - "The aim of the present study was to investigate the effect of a fermented milk product containing Ile-Pro-Pro and Val-Pro-Pro and plant sterols on already established hypertension, endothelial dysfunction and aortic gene expression. "
01/01/2012 - "Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension."
01/01/2011 - "Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension."
01/01/2014 - "The milk casein-derived bioactive tripeptides isoleucine-proline-proline (IPP) and valine-proline-proline (VPP) have been shown to prevent development of hypertension in animal models and to lower blood pressure in moderately hypertensive subjects in most but not all clinical trials. "
08/28/2014 - "Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice."
01/01/2015 - "Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells."
01/01/1993 - "The immunosuppressive activity of a linear peptide related to cyclolinopeptide A, Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-Phe, and its nine analogs, where each successive amino acid residue was substituted by alanine, was investigated using the plaque forming cell and delayed type hypersensitivity tests for the humoral and cellular immune response, respectively. "
|5.||Cardiovascular Diseases (Cardiovascular Disease)
01/01/2012 - "Our aim was to evaluate the predictors of Isoleucine-Proline-Proline/Valine-Proline-Proline (IPP-VPP) lactotripeptides (LTPs) antihypertensive effect in the context of a short-term large double-blind randomized clinical trial involving 164 pharmacologically untreated subjects in primary prevention for cardiovascular disease. "
|3.||indolepropanol phosphate (IPP)
|5.||Phytosterols (Plant Sterols)
|8.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)